Monday, January 25, 2021

COVID-19: Oxford University’s Coronavirus Antibody Test Proves Successful

The UK is set to start distributing millions of free coronavirus (COVID-19) antibody tests after successful trials by Oxford University, local media reported on Saturday.

The finger-prick tests can tell within 20 minutes if a person has been exposed to the virus and were found to be 98.6% accurate during human trials that took place in June. The test was developed under a partnership between Oxford University and leading diagnostics firms of the UK.

Sir John Bell, professor of medicine at Oxford University and head of the government’s antibody testing program, was quoted by The Telegraph as saying: “This rapid test appears to be truly amazing, and it shows we can do this ourselves.”

Meanwhile, clinical trials to test a new coronavirus vaccine developed by Imperial College London are progressing to their next phase, the university announced.

After a successful initial round of testing on 15 volunteers, 105 more participants will be given the vaccine. The first 15 volunteers will return to receive a second dose as well.

“We have had a promising start but it remains too early to speculate whether our vaccine candidate will be effective in preventing infection,” said Dr Katrina Pollock, clinical lead on the study.

“The early clinical trials are progressing well and I would like to thank all those who are supporting this work, particularly our trial volunteers.”

Professor Robin Shattock, who is leading the development of the vaccine, said: “The progression to the next phase of the trial is an important step in assessing the safety of our vaccine. Analyzing blood samples for antibodies and T-cell response will provide some indication of whether our vaccine can produce an immune response to fight the virus.”

“Larger clinical trials will still be needed to tell us whether our vaccine candidate and any other COVID-19 vaccine in development, may be successful in reducing the spread or severity of COVID-19.”

The UK government has invested over £40 million in the Imperial vaccine, as well as investing in the Oxford vaccine, which is currently leading in the global race for a method of immunization from the novel coronavirus.

Featured

Did Iran’s Ayatollah Khamenei Threaten To ‘Take-Out’ Donald Trump Over Qasem Soleimani’s Assassination?

A Twitter account linked to Iran’s Supreme Leader Ayatollah Ali Khamenei was on Friday banned by the microblogging site for posting an image, in...

Russia To Supply Pantsir-S1 Air Defense System To Myanmar Amid Warming Ties With India, Japan

As India and Japan are getting closer to Myanmar militarily to counter China, the Southeast Asian nation has not forgotten its old ally Russia....

India, Saudi Arabia Ties ‘Under Duress’ After Riyadh Introduces A New Economic Measure?

Just when India’s coronavirus-battered economy started showing signs of recovery, Saudi Arabia's decision to cut crude oil production does not augur well for the...

​China’s Growing Global Stature As Weapons Producer Threatens Russia’s Export Revenues

China overtook Russia to become the world's No. 2 arms producer between 2015 and 2019, according to data released by the Stockholm International Peace...

Why Anti-Israel Rhetoric Keeps Resurfacing In Pakistan Despite Imran Khan Ruling Out Ties With Jewish State?

Pakistan is witnessing a wide-scale anti-Israel movement led by Maulana Fazlur Rehman of the Jamiat Ulema-e Islam (Fazl), a right-wing Islamist party, which opposes...